Prevention and treatment of upper respiratory diseases in the pandemic COVID-19 era

D. Passali, L.M. Bellussi, F.M. Passali, R. De Hoyos, S. Di Girolamo, G. Ciprandi

Article ID: 5536
Vol 35, Issue 1S2, 2021
DOI: https://doi.org/10.23812/21-1supp2-2
Received: 11 March 2021; Accepted: 11 March 2021; Available online: 11 March 2021; Issue release: 11 March 2021

Abstract

In the pandemic coronavirus disease 2019 (COVID-19) era, the need to use preventive-curative treatments is compelling. A series of non-pharmacological compounds, including oligo-elements, vitamins, nutraceuticals, and bacteriotherapy, might affect the risk of COVID-19, both reinforcing the immune system and improving the inflammation resolution during respiratory infections. Non-pharmacological remedies are very popular and usually have no relevant side effects. Bacterial and natural products may potentiate the immune system against respiratory viruses. Moreover, these compounds also exert antiinflammatory and antioxidant activity. Consequently, these non-chemical remedies could be prescribed to build up the immune defence and adequately treat the upper respiratory infection. In this way, natural compounds could be used to manage people in the pandemic COVID-19 era.


Keywords

COVID-19;upper respiratory infections;microbiota;bacteriotherapy;oligo-elements;nutraceuticals


References

Supporting Agencies



Copyright (c) 2021 D. Passali, L.M. Bellussi, F.M. Passali, R. De Hoyos, S. Di Girolamo, G. Ciprandi




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).